A phenotypic study of cells from burkitt lymphoma and ebv‐b‐lymphoblastoid lines and their relationship to cells in normal lymphoid tissues

No abstract is available for this paper.

• Publication year

  1989

• Venue

  International Journal of Cancer

• Publication date

  1989-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/IJC.2910430122PMID 2536003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma.

  1988cited by this paper
• Analysis of somatic mutation and class switching in naive and memory B cells generating adoptive primary and secondary responses.

  1987cited by this paper
• Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype.

  1987cited by this paper
• Mutation Drift and Repertoire Shift in the Maturation of the Immune Response

  1987cited by this paper
• Expression of B‐cell‐specific markers in different burkitt lymphoma subgroups

  1987cited by this paper
• Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

  1987cited by this paper
• Antigen‐Driven Selection of Virgin and Memory B Cells

  1986cited by this paper
• The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.

  1986cited by this paper
• Heterogeneity of EBV-transformable human B lymphocyte populations.

  1986cited by this paper
• Surface phenotype and function of tonsillar germinal center and mantle zone B cell subsets.

  1986cited by this paper
• Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

  1986cited by this paper
• EBV‐negative and ‐positive burkitt cell lines variably express receptors for B‐cell activation and differentiation

  1986cited by this paper
• The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V–D–J joining

  1986cited by this paper
• Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines.

  1986cited by this paper
• Myc/Ig juxtaposition by chromosomal translocations: some new insights, puzzles and paradoxes.

  1985cited by this paper
• Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.

  1985cited by this paper
• Evolution of tumours and the impact of molecular oncology

  1985cited by this paper
• Variants of lymphoid lines produced with ricin A-chain monoclonal antibody conjugates.

  1985cited by this paper
• A method for simultaneous nuclear immunofluorescence and DNA content quantitation using monoclonal antibodies and flow cytometry.

  1985cited by this paper
• Expression of the bla antigen, defined by the monoclonal 38.13 antibody, on burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other b‐cell lymphomas and leukemias

  1983cited by this paper
• Detection of free kappa chains in human serum and urine using pairs of monoclonal antibodies reacting with C kappa epitopes not available on whole immunoglobulins.

  1983cited by this paper
• A human‐human hybridoma system based on a fast‐growing mutant of the ARH‐77 plasma cell leukemia‐derived line

  1982cited by this paper
• Monoclonal antibodies to epstein‐barr virus‐induced, transformation‐associated cell surface antigens: Binding patterns and effect upon virus‐specific t‐cell cytotoxicity

  1982cited by this paper
• Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas

  1982cited by this paper
• Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.

  1982cited by this paper
• Monoclonal antibody against a Burkitt lymphoma-associated antigen.

  1981cited by this paper
• Malignant Lymphomas Other than Hodgkin’s Disease

  1978cited by this paper
• Immunohistochemical identification of T- and B-lymphocytes delineated by the unlabeled antibody enzyme method. I. Anatomical distribution of theta-positive and Ig-positive cells in lymphoid organs of mice.

  1976cited by this paper
• Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers.

  1976cited by this paper
• Failure to detect antibody against Gross virus in tetraparental AKR reversible CBA mouse chimaeras.

  1975cited by this paper
• New approaches to the classification of the lymphomata.

  1975cited by this paper
• The effect of sex hormones on the growth of HeLa tumour nodules in male and female mice.

  1975cited by this paper
• Human lymphoblastoid cell lines. 3. Co-cultivation technique for establishment of new lines.

  1972cited by this paper
• Epidemiologic and immunologic considerations on the pathogenesis of Burkitt's Tumor.

  1972cited by this paper
• Sensitivity of Epstein‐Barr virus (EBV) producer and non‐producer human lymphoblastoid cell lines to superinfection with EB‐virus

  1972cited by this paper
• Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines.

  1972cited by this paper
• Evidence of altered antigenicity in cultured lymphoid cells from patients with infectious mononucleosis.

  1970cited by this paper
• Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

  1968cited by this paper
• Preliminary observations on new lymphoblast strains (EB4, EB5) from Burkitt tumours in a British and a Ugandan patient.

  1966cited by this paper
• Studies with Burkitt's lymphoma.

  1965cited by this paper
• A study of malignant tumours in Nigeria by short-term tissue culture

  1965cited by this paper
• Malignant lymphoma in African children. II. A pathological entity

  1961cited by this paper

• The Role of Purinergic Signalling in Inflammatory Disorders

  2019cites this paper
• Nouveaux rôles anti-tumoraux de STAT1 : expression des immunoglobulines et réparation de l'ADN

  2014cites this paper
• for Ex Vivo Tumor Purging and Autologous Stem Cell Transplantation Implications Myeloma and Absence From CD34+ Hematopoietic Stem Cells: Shiga-Like Toxin-1 Receptor on Human Breast Cancer, Lymphoma, and

  2013cites this paper
• STAT1 and pathogens, not a friendly relationship

  2010cites this paper
• Die Rolle des Epstein-Barr Virus in der Lymphompathogenese

  2009cites this paper
• Structure and consequences of IGH switch breakpoints in Burkitt lymphoma.

  2008cites this paper
• EBV transformation overrides gene expression patterns of B cell differentiation stages.

  2008cites this paper
• Regulation of the STAT1 by the Epstein-Barr virus.

  2007cites this paper
• Study of nuclear targets of phosphatidylinositol-3 kinase in lymphocytes

  2006cites this paper
• c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient.

  2006cites this paper
• The Human CD77− B Cell Population Represents a Heterogeneous Subset of Cells Comprising Centroblasts, Centrocytes, and Plasmablasts, Prompting Phenotypical Revision1

  2006influential citation
• Expression and function of the small immune adaptor protein SAP

  2006cites this paper
• Effects of SolCD39, a Novel Inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model

  2005cites this paper
• CD 39-associated high ATPase activity contribute to the loss of P 2 X 7-mediated calcium response in LCL cells.

  2005cites this paper
• B cells under influence: transformation of B cells by Epstein–Barr virus

  2003cites this paper
• CD24 Induces Apoptosis in Human B Cells Via the Glycolipid-Enriched Membrane Domains/Rafts-Mediated Signaling System1

  2001cites this paper
• GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.

  2001cites this paper
• Soluble apyrases release adp during ATP hydrolysis.

  2001cites this paper
• Role of LMP1 in immune control of EBV infection.

  2001cites this paper
• Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells.

  2000cites this paper
• A Novel B Lymphocyte–Associated Adaptor Protein, Bam32, Regulates Antigen Receptor Signaling Downstream of Phosphatidylinositol 3-Kinase

  2000cites this paper
• Reconstitution of the cellular immune response after autologous peripheral blood stem cell transplantation in patients with non‐Hodgkin's lymphoma

  2000cites this paper
• Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment.

  2000cites this paper
• glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating Lyn kinase activity in human B cells

  2000cites this paper
• Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.

  1999cites this paper
• Somatic mutations and intraclonal variations in the rearranged Vk genes of B‐non‐Hodgkin's lymphoma cell lines

  1999cites this paper
• TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.

  1998cites this paper
• The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease.

  1998cites this paper
• Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.

  1998cites this paper
• Ligation of CD 40 on Human B Cells Kinase , Cytokine Secretion , and Ig Production Mediates Activation of p 38 and Jun N-Terminal TNF Receptor-Associated Factor-3 Signaling

  1998cites this paper
• Germinal Center Derived Lymphomas in Humans and Mice

  1998cites this paper
• The A-myb transcription factor in neoplastic and normal B cells.

  1997cites this paper
• Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias

  1996cites this paper
• Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.

  1996cites this paper
• The physiology of germinal centers.

  1996cites this paper
• Centrocytes rapidly adopt a memory B cell phenotype on co-culture with autologous germinal centre T cell-enriched preparations.

  1996cites this paper
• Isolation and characteristics of tonsil centroblasts with reference to Ig class switching.

  1995cites this paper
• Differential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt's lymphoma cell lines

  1995cites this paper
• Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus.

  1995cites this paper
• Burkitt’s Lymphoma Is a Malignancy of Mature B Cells Expressing Somatically Mutated V Region Genes

  1995cites this paper
• Gene Expression in Burkitt’s Lymphoma Cells

  1994cites this paper
• Germinal centers.

  1994cites this paper
• A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma.

  1994cites this paper
• Biased utilization of immunoglobulin variable region heavy‐ and light‐chain genes by the malignant CD5‐ B lymphocytes from patients with Burkitt's lymphoma

  1994cites this paper
• The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization.

  1994cites this paper
• Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors.

  1994cites this paper
• The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.

  1994cites this paper
• Phenotypic and functional heterogeneity of the IgD- B cell compartment: identification of two major tonsillar B cell subsets.

  1993cites this paper
• Identification of two distinct CD5‐ B cell subsets from human tonsils with different responses to CD40 monoclonal antibody

  1993cites this paper
• The effect of IL-4 on the phenotype of a human B-cell lymphoma line (Farage) lacking immunoglobulin expression.

  1993cites this paper
• The Path of Memory B‐Cell Development

  1992cites this paper
• Properties of soluble CR2 in human serum.

  1992cites this paper
• Evolution of clonality and invasive behavior of Epstein-Barr virus immortalized lymphoblastoid cell lines in SCID mice brains.

  1992cites this paper
• Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes.

  1991cites this paper
• Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL)

  1991cites this paper
• Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia

  1991cites this paper
• Human B-lymphoid differentiation: normal versus malignant.

  1991cites this paper
• CD77: an antigen of germinal center B cells entering apoptosis

  1991cites this paper
• Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin section

  1990cites this paper